ImageneBio, a clinical-stage biotech company focused on immunological and autoimmune diseases, announced that CEO Kristin Yarema will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026. The company is currently conducting a Phase 2b trial for its drug IMG-007 targeting atopic dermatitis and plans further studies in alopecia areata. This presentation offers investors insights into the company's progress and upcoming clinical developments. Management will also hold one-on-one meetings during the event.
Alterra IOS, a leader in industrial outdoor storage (IOS), secured a $244 million loan from Blackstone Real Estate Debt Strategies to support its growing platform. The loan covers 37 properties across 27 U.S. markets, totaling 165 acres and 806,000 s...
Rexel Développement SAS has released a statement confirming the total number of shares and voting rights as of May 31, 2026. The company reports 296,997,254 shares in total, with a theoretical voting right count matching this number. The exercisable ...
Rexel Développement SAS has declared the total number of its shares and voting rights as of May 31, 2026. The company has 296,997,254 shares in total, with the same number of theoretical voting rights. However, the exercisable voting rights, excludin...
At Garmin Ltd.'s annual shareholders meeting, a cash dividend of $4.20 per share was approved, to be paid in four equal quarterly installments through March 2027. The first installment of $1.05 will be paid on June 26, 2026, with subsequent payments ...
Ipsos has named Marion Beyret as its new Global Director of Communications, effective immediately. Beyret brings 15 years of experience from media, politics, and major international companies, previously leading communications at Stellantis and Air F...
